ACR Convergence keynote: AI already impacting CAR T-cell trial design - Healio
He described an AI model that assessed 1,758 binders targeting B-cell maturation antigen (BCMA), CD-19 and CD-22. “They tested the binders in ...
- Tracked via
- “An AI Model that”